GlaxoSmithKline PLC Director/PDMR Shareholding

Data : 11/12/2019 @ 17:57
Fonte : UK Regulatory (RNS & others)
Titolo : Glaxosmithkline Plc (GSK)
Quotazione : 1658.2  8.2 (0.50%) @ 17:35
Quotazione Glaxosmithkline Grafico

GlaxoSmithKline PLC Director/PDMR Shareholding

Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico

3 Mesi : Da Nov 2019 a Feb 2020

Clicca qui per i Grafici di Glaxosmithkline

TIDMGSK

RNS Number : 5780W

GlaxoSmithKline PLC

11 December 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Ms E Walmsley 
===  ============================  ================================================= 
 b)   Position/status              Chief Executive Officer 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan. 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            16 Ordinary Shares 
       Price                        GBP17.3090 
===  ============================  ================================================= 
 e)   Date of the transaction      2019-12-10 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Mr R Connor 
===  ============================  ================================================= 
 b)   Position/status              President, Global Vaccines 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan. 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            16 Ordinary Shares 
       Price                        GBP17.3090 
===  ============================  ================================================= 
 e)   Date of the transaction      2019-12-10 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Ms D Conrad 
===  ============================  ================================================= 
 b)   Position/status              SVP, Human Resources 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan. 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            16 Ordinary Shares 
       Price                        GBP17.3090 
===  ============================  ================================================= 
 e)   Date of the transaction      2019-12-10 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Mr N Hirons 
===  ============================  ================================================= 
 b)   Position/status              SVP, Global Ethics and Compliance 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan. 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            16 Ordinary Shares 
       Price                        GBP17.3090 
===  ============================  ================================================= 
 e)   Date of the transaction      2019-12-10 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Ms S Jackson 
===  ============================  ================================================= 
 b)   Position/status              SVP, Global Communications and CEO Office 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan. 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            16 Ordinary Shares 
       Price                        GBP17.3090 
===  ============================  ================================================= 
 e)   Date of the transaction      2019-12-10 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =================================================================================== 
 a)   Name                         Mr D Jackson 
===  ============================  ===================================================== 
 b)   Position/status              PCA of Ms S Jackson (SVP, Global Communications 
                                    and CEO Office) 
===  ============================  ===================================================== 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ===================================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =================================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ===================================================== 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ===================================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =================================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ===================================================== 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan. 
===  ============================  ===================================================== 
 c)   Price(s) and                   Price(s)          Volume(s) 
       volume(s) 
===  ============================    ================  =============================== 
                                     GBP17.3090        7 (partnership shares) 
===  ============================    ================  =============================== 
                                     GBP17.3090        7 (matching shares) 
                                     ================  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume            14 Ordinary Shares 
       Price                        GBP17.3090 
===  ============================  ===================================================== 
 e)   Date of the transaction      2019-12-10 
===  ============================  ===================================================== 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ===================================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Mr D Redfern 
===  ============================  ================================================= 
 b)   Position/status              Chief Strategy Officer 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan. 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            16 Ordinary Shares 
       Price                        GBP17.3090 
===  ============================  ================================================= 
 e)   Date of the transaction      2019-12-10 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Mr R Simard 
===  ============================  ================================================= 
 b)   Position/status              President, Pharmaceutical Supply Chain 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan. 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      7 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      7 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            14 Ordinary Shares 
       Price                        GBP17.3090 
===  ============================  ================================================= 
 e)   Date of the transaction      2019-12-10 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Mr P Thomson 
===  ============================  ================================================= 
 b)   Position/status              President, Global Affairs 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan. 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      7 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      7 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            14 Ordinary Shares 
       Price                        GBP17.3090 
===  ============================  ================================================= 
 e)   Date of the transaction      2019-12-10 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  =============================================================================== 
 a)   Name                         Ms V Whyte 
===  ============================  ================================================= 
 b)   Position/status              Company Secretary 
===  ============================  ================================================= 
 c)   Initial notification/        Initial notification 
       amendment 
===  ============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =============================================================================== 
 a)   Name                         GlaxoSmithKline plc 
===  ============================  ================================================= 
 b)   LEI                          5493000HZTVUYLO1D793 
===  ============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =============================================================================== 
 a)   Description of               Ordinary shares of 25 pence each ('Ordinary 
       the financial                Shares') 
       instrument                   ISIN: GB0009252882 
===  ============================  ================================================= 
 b)   Nature of the                Acquisition of Ordinary Shares under the 
       transaction                  Company's Share Reward Plan. 
===  ============================  ================================================= 
 c)   Price(s) and                   Price(s)        Volume(s) 
       volume(s) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (partnership shares) 
===  ============================    ==============  ============================= 
                                     GBP17.3090      8 (matching shares) 
                                     ==============  ============================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume            16 Ordinary Shares 
       Price                        GBP17.3090 
===  ============================  ================================================= 
 e)   Date of the transaction      2019-12-10 
===  ============================  ================================================= 
 f)   Place of the                 London Stock Exchange (XLON) 
       transaction 
===  ============================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQFLFFKLFEFBX

(END) Dow Jones Newswires

December 11, 2019 11:57 ET (16:57 GMT)

La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V:it D:20200222 14:33:27